Medicine and Dentistry
Nonalcoholic Fatty Liver
100%
Fibrosis
46%
Stomach Paresis
29%
Symptom
19%
Pediatrics
13%
Liver Fibrosis
12%
Liver Histology
11%
Diabetes
11%
Clinical Research
11%
Stomach Emptying
10%
Maturity Onset Diabetes of the Young
9%
Non-Alcoholic Fatty Liver Disease
9%
Placebo
8%
Biopsy
7%
Body Mass Index
7%
Hepatocyte
6%
Premenopause
6%
Steatohepatitis
6%
Quality of Life
6%
Prevalence
6%
Metabolic Dysfunction-Associated Steatotic Liver Disease
6%
Alpha Tocopherol
5%
Fatty Liver
5%
Alanine Aminotransferase
5%
Disease Severity
5%
Liver Disease
5%
Odds Ratio
5%
Obeticholic Acid
5%
PNPLA3
5%
Keyphrases
Non-alcoholic Fatty Liver Disease (NAFLD)
56%
Nonalcoholic Steatohepatitis
34%
Gastroparesis
27%
Fibrosis
17%
Liver Histology
11%
Advanced Fibrosis
11%
Metabolic-associated Fatty Liver Disease (MAFLD)
9%
Histologic
8%
Refractory Gastroparesis
8%
Fibrosis Stage
8%
Postmenopausal Women
8%
Clinical Trials Network
6%
Diabetic Gastroparesis
6%
Vitamin E
6%
Hispanic
5%
Gastric Emptying
5%
Biopsy-proven
5%
Diabetes
5%
Placebo
5%
Steatosis
5%
Confidence Interval
5%
Pediatric Nonalcoholic Fatty Liver Disease
5%
PNPLA3
5%
Metabolic Syndrome
5%
Pharmacology, Toxicology and Pharmaceutical Science
Nonalcoholic Fatty Liver
66%
Fibrosis
35%
Stomach Paresis
23%
Symptom
15%
Liver Fibrosis
15%
Liver Disease
11%
Alpha Tocopherol
11%
Placebo
8%
Disease Severity
6%
Alanine Aminotransferase
6%
Clinical Research
6%
Prevalence
6%
Nausea and Vomiting
5%
Inflammation
5%
